This content is machine translated 9th Zurich Hypertension Day Relaxed blood pressure targets for high-risk patients The 9th Zurich Hypertension Day focused on the changes to the European Hypertension Guidelines and the treatment of important concomitant or secondary diseases such as atrial fibrillation.
View Post 9 min This content is machine translated New oral anticoagulants 10 questions from daily use The new oral anticoagulants (NOAKs) have long since become part of everyday clinical practice in stroke prophylaxis for atrial fibrillation. Due to their simpler, safer, and effective use, they are…
View Post 6 min This content is machine translated Chronic heart failure and stroke prevention in VHF. Optimized treatment regimens and new therapeutic options The December lecture series in Zurich featured a presentation by PD Georg Noll, MD, on the treatment of chronic heart failure, in which he shared his practical clinical experience. The…
View Post 7 min This content is machine translated 4th Bern Heart Valve Symposium New transfemoral TAVI systems and the Swiss TAVI Registry The new transfemoral TAVI systems, either in development or already certified, address potential vulnerabilities and limitations, such as paravalvular insufficiency or risk of vascular complication. This article, based on a…
View Post 4 min This content is machine translated Interview on the ACC/AHA guidelines Lipid treatment recommendation meets with little approval Statins continue to be the drug of choice for LDL-C therapy, although not all patients achieve their target levels with therapy alone. However, the paradigm shift implemented in the new…
View Post 6 min This content is machine translated Anticoagulation in cardiac assist devices No study results with new oral anticoagulants to date. Anticoagulation must be individualized to the support system and patient. Patients with non-pulsatile systems have been shown to have acquired von Willebrand syndrome, which increases the risk for bleeding complications.…
View Post 7 min This content is machine translated Proteinuria What clarifications and therapeutic measures are to be taken? Proteinuria must always be taken seriously. Further clarification depends on the clinic, the severity of proteinuria, and whether there is concomitant microhematuria and/or renal insufficiency. If glomerular disease is suspected,…
View Post 4 min This content is machine translated Zurich Cardiovascular Day Stroke treatment news The results of the IMS-III trial show that endovascular therapy for acute stroke is not yet mature. Regardless of this, they once again emphasize the time factor in stroke treatment.…
View Post 3 min This content is machine translated Aliskiren Good blood pressure control in combination with HCT Aliskiren, a renin inhibitor that reduces the amount of angiotensin II, is available as a monotherapy (Rasilez®) and in combination with hydrochlorothiazide (Rasilez HCT®). Recent real-world studies and meta-analyses confirm…
View Post 3 min This content is machine translated Successful therapy of pAVD with EGb 761®. Clinical studies document the efficacy of Ginkgo biloba extract Peripheral arterial disease (PAVD) often occurs as a result of atherosclerosis, with varying prevalence depending on age. Men are more commonly affected than women [1], and in two-thirds of all…
View Post 3 min This content is machine translated Surgical revascularization for CHD OPCAB technique not better than bypass surgery with extracorporeal circulation. The use of the heart-lung machine (HLM) is considered the worldwide standard for surgical myocardial revascularization in combination with cardiac immobilization. Inflammatory reactions due to larger foreign surface area may…
